Viewing Study NCT04185220

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2025-12-26 @ 3:18 AM
Study NCT ID: NCT04185220
Status: COMPLETED
Last Update Posted: 2023-01-04
First Post: 2019-12-03
Is NOT Gene Therapy: False
Has Adverse Events: True
Brief Title: Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult T-Cell Lymphoma/Leukemia View
None Sezary Syndrome View
None Mycosis Fungoides View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Antibody-Dependent Cell Cytotoxicity (ADCC) View
None CCR4 View
None Monoclonal Antibody View